NDUFB9-TDRKH Fusion FISH Probe
The NDUFB9-TDRKH Fusion FISH Probe is used to confirm a fusion of the NDUFB9 and TDRKH genes. The fusion of the NDUFB9 and TDRKH genes has been associated with Breast Invasive Carcinoma, and Breast Invasive Carcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| NDUFB9-TDRKH-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-RERE | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-REOR | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-REGO | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-REGR | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-OROR | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-GORE | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-GROR | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| NDUFB9-TDRKH-20-AQAQ | 20 (40 μL) | 200 μL |
|
NDUFB9 Gene Summary
The protein encoded by this gene is a subunit of the mitochondrial oxidative phosphorylation complex I (nicotinamide adenine dinucleotide: ubiquinone oxidoreductase). Complex I is localized to the inner mitochondrial membrane and functions to dehydrogenate nicotinamide adenine dinucleotide and to shuttle electrons to coenzyme Q. Complex I deficiency is the most common defect found in oxidative phosphorylation disorders and results in a range of conditions, including lethal neonatal disease, hypertrophic cardiomyopathy, liver disease, and adult-onset neurodegenerative disorders. Pseudogenes of this gene are found on chromosomes five, seven and eight. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2015]
Gene Name: NADH:ubiquinone Oxidoreductase Subunit B9
Chromosome: CHR8: 125551342 -125562227
Locus: 8q24.13
TDRKH Gene Summary
The Tudor And KH Domain Containing (TDRKH) gene is located on chr1 :151744040-151763010 at 1q21.3.
Gene Name: Tudor And KH Domain Containing
Chromosome: CHR1: 151744040 -151763010
Locus: 1q21.3
Gene Diseases
The NDUFB9 TDRKH Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Breast Invasive Carcinoma |
| Breast Invasive Carcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|